Scientists at the Scripps Research Institute say they've identified an enzyme necessary for maintaining the stability of hematopoietic stem cells. The advance with Inositol trisphosphate 3-kinase B (ItpkB) is being billed as an important step forward in "improving therapies for diseases such as bone marrow failure syndrome, anemia, leukemia, lymphoma and immunodeficiencies." Release